Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issa Nebie

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Elife|September 20, 2017
Major transcriptional changes observed in the Fulani, an ethnic group less susceptible to malariaJaclyn E Quin, Ioana Bujila, Mariama Chérif, et al.
Frontiers in Immunology|April 20, 2026
IgG and IgM responses to PfEMP1 domains associated with semi-immunity to clinical malaria in Burkinabe children under fiveBenedicta O Dankyi, Takaaki Yuguchi, Rattanaporn Rojrung, et al.
Infection and Immunity|October 5, 2011
Naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs48/45 and Pfs230 in an area of seasonal transmissionAndré Lin Ouédraogo, Will Roeffen, Adrian J F Luty, et al.
BMC Medicine|March 9, 2016
Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trialBronner P Gonçalves, Alfred B Tiono, Alphonse Ouédraogo, et al.
Biorxiv : the Preprint Server for Biology|April 25, 2024
Cross-reactivity of r<i>Pvs</i>48/45, a recombinant <i>Plasmodium vivax</i> protein, with sera from <i>Plasmodium falciparum</i> endemic areas of AfricaSaidou Balam, Kazutoyo Miura, Imen Ayadi, et al.
Plos One|March 18, 2025
Cross-reactivity of rPvs48/45, a recombinant Plasmodium vivax protein, with plasma from Plasmodium falciparum endemic areas of AfricaSaidou Balam, Kazutoyo Miura, Imen Ayadi, et al.
Plos One|January 16, 2013
Malaria morbidity in high and seasonal malaria transmission area of Burkina FasoAlphonse Ouédraogo, Alfred B Tiono, Amidou Diarra, et al.
Frontiers in Cellular and Infection Microbiology|January 2, 2023
African-specific polymorphisms in <i>Plasmodium falciparum</i> serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccinationNobuko Arisue, Nirianne Marie Q Palacpac, Edward H Ntege, et al.
Plos Neglected Tropical Diseases|September 18, 2024
Comparative evaluation of plasma biomarkers of Schistosoma haematobium infection in endemic populations from Burkina FasoMireille Ouedraogo, Jana Christina Hey, Stan Hilt, et al.
Frontiers in Immunology|September 19, 2022
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe childrenEdith Christiane Bougouma, Nirianne Marie Q Palacpac, Alfred B Tiono, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Elife|September 20, 2017
Major transcriptional changes observed in the Fulani, an ethnic group less susceptible to malariaJaclyn E Quin, Ioana Bujila, Mariama Chérif, et al.
Frontiers in Immunology|April 20, 2026
IgG and IgM responses to PfEMP1 domains associated with semi-immunity to clinical malaria in Burkinabe children under fiveBenedicta O Dankyi, Takaaki Yuguchi, Rattanaporn Rojrung, et al.
Infection and Immunity|October 5, 2011
Naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs48/45 and Pfs230 in an area of seasonal transmissionAndré Lin Ouédraogo, Will Roeffen, Adrian J F Luty, et al.
BMC Medicine|March 9, 2016
Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trialBronner P Gonçalves, Alfred B Tiono, Alphonse Ouédraogo, et al.
Biorxiv : the Preprint Server for Biology|April 25, 2024
Cross-reactivity of r<i>Pvs</i>48/45, a recombinant <i>Plasmodium vivax</i> protein, with sera from <i>Plasmodium falciparum</i> endemic areas of AfricaSaidou Balam, Kazutoyo Miura, Imen Ayadi, et al.
Plos One|March 18, 2025
Cross-reactivity of rPvs48/45, a recombinant Plasmodium vivax protein, with plasma from Plasmodium falciparum endemic areas of AfricaSaidou Balam, Kazutoyo Miura, Imen Ayadi, et al.
Plos One|January 16, 2013
Malaria morbidity in high and seasonal malaria transmission area of Burkina FasoAlphonse Ouédraogo, Alfred B Tiono, Amidou Diarra, et al.
Frontiers in Cellular and Infection Microbiology|January 2, 2023
African-specific polymorphisms in <i>Plasmodium falciparum</i> serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccinationNobuko Arisue, Nirianne Marie Q Palacpac, Edward H Ntege, et al.
Plos Neglected Tropical Diseases|September 18, 2024
Comparative evaluation of plasma biomarkers of Schistosoma haematobium infection in endemic populations from Burkina FasoMireille Ouedraogo, Jana Christina Hey, Stan Hilt, et al.
Frontiers in Immunology|September 19, 2022
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe childrenEdith Christiane Bougouma, Nirianne Marie Q Palacpac, Alfred B Tiono, et al.
Pageof 5